摘要
TI-201 has been used mainly as a myocardial perfusion agent. Its use as a tumor agent was first described in 1976, and many types of malignancies have been detected with TI-201. However, scintigraphic detection of esophageal cancer by TI-201 has rarely been reported.
原文 | 英語 |
---|---|
頁(從 - 到) | 77 |
頁數 | 1 |
期刊 | Clinical Nuclear Medicine |
卷 | 28 |
發行號 | 1 |
DOIs | |
出版狀態 | 已發佈 - 1月 2003 |
對外發佈 | 是 |
ASJC Scopus subject areas
- 放射學、核子醫學和影像學